Close Menu

technology evaluation agreement

Public Health England will use the company's Victor EnLite instrument and EnLite Neonatal TREC kit at three of six sites to evaluate screening newborns for "Bubble Boy" disease.

The platform matches a patient's medical history and other data with national guidelines to recommended medically actionable genetic tests.

Under the agreement, the Leidos-operated Frederick National Lab will evaluate Resolution's ctDx liquid biopsy sequencing platform.

The French firm is assessing the Roche Cobas HPV test in preparation for a global Phase III clinical trial of its own therapeutic HPV vaccine.

Clovis hopes Sysmex's BEAMing test will work better than FFPE tests to identify candidates for treatment with rociletinib, its investigational EGFR inhibitor.

NEW YORK (GenomeWeb News) – PathoGenetix today said that Marshfield Food Safety will evaluate and provide feedback on PathoGenetix's Resolution Microbial Genotyping System.

NEW YORK (GenomeWeb News) – Hurel today said that it has entered into a research and development collaboration with Sanofi to evaluate the use of Hurel's cell-based products and technologies for preclinical drug development.

NEW YORK (GenomeWeb News) – PathoGenetix and the US Department of Agriculture's Agricultural Research Service announced late on Monday the evaluation of PathoGenetix's technology for identifying strains of Shiga-toxin-producing E. coli, or STECs, and Salmonella enterica.

NEW YORK (GenomeWeb News) – Two hospitals in the Netherlands — the University Medical Center Groningen and Amphia Hospital — plan to evaluate and adopt Pathogenica's next-generation sequencing-based HAI BioDetection Kit in the surveillance and monitoring of infectious bacteria, the company said t

NEW YORK (GenomeWeb News) – The Brazilian agricultural technology firm FuturaGene said today that the Donald Danforth Plant Science Center will test FuturaGene's plant yield technology on staple crops grown by farmers in Asia, Africa, and Brazil.

Pages

Two COVID-19 vaccine developers have released their trial protocols to build public trust, the New York Times reports.

A new analysis finds the rapid COVID-19 test from DnaNudge to be highly accurate, Reuters reports.

In Science this week: global citizens' assembly on genome-editing technologies proposed, epigenetic markers predict metformin response, and more.

According to the Verge, many US states are not including positive results from rapid COVID-19 testing in their case numbers.